Latest News - The Aurum Institute

Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.

Nazziwa, J., Freyhult, E., Hong, M.G., Johansson, E., Årman, F., Hare, J., Gounder, K., Rezeli, M., Mohanty, T., Kjellström, S. and Kamali, A., 2024. Dynamics of the blood plasma proteome during hyp...
Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatment.

Cumming, B.M., Addicott, K.W., Maruri, F., Pillay, V., Asmal, R., Moodley, S., Barreto-Durate, B., Araújo-Pereira, M., Mazibuko, M., Mhlane, Z. and Mbatha, N., 2024. Longitudinal mitochondrial bioene...
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.

Kelley, C.F., Acevedo-Quiñones, M., Agwu, A.L., Avihingsanon, A., Benson, P., Blumenthal, J., Brinson, C., Brites, C., Cahn, P., Cantos, V.D. and Clark, J., 2024. Twice-Yearly Lenacapavir for HIV Pre...
WhatsApp Versus SMS for 2-Way, Text-Based Follow-Up After Voluntary Medical Male Circumcision in South Africa: Exploration of Messaging Platform Choice.

Fabens, I., Makhele, C., Igaba, N.K., Hlongwane, S., Phohole, M., Waweru, E., Oni, F., Khwepeya, M., Sardini, M., Moyo, K. and Tweya, H., 2024. WhatsApp versus SMS for 2-way, text-based follow-up afte...
Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Naicker, V., Laher, F., Bekker, L.G., Seaton, K.E., Allen, M., De Rosa, S., Yates, N.L., Mkhize, N.N., Saunders, K., Heptinstall, J. and Malahleha, M., 2024. Safety and immunogenicity after a 30-month...
Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-imp

Myers, H., Chongo, B., Zifodya, J.S., Zacaria, I., Machava, E., Simango, A., Amorim, G., Mavume-Mangunyane, E., Chiau, R., Kampa, K.T. and Madede, T., 2024. Implementation of spirometry screening for ...
Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial

Bennett, C., Hoosain, Z., Koen, A., Lalloo, U., Louw, C., Maluleke, V., Patel, F., Benade, G., Venter, E.L., Galbiati, S. and Shinde, V., 2024. Immunogenicity and safety of SARS-CoV-2 recombinant spik...
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.

Huang, Y., Alam, S., Andersen-Nissen, E., Carpp, L.N., Dintwe, O.B., Flach, B.S., Grunenberg, N., Laher, F., De Rosa, S.C., Ferrari, G. and Innes, C., 2024. Non-HIV Vaccine-Induced Immune Responses as...
Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis:

Four pragmatic, cluster-randomised trials Jerene, D., van Kalmthout, K., Levy, J., Alacapa, J., Deyanova, N., Dube, T., Mganga, A., Tasca, B., Bogdanov, A., Efo, E. and Gamazina, K., 2025. Effect o...
WHO global research priorities for antimicrobial resistance in human health.

Bertagnolio, S., Dobreva, Z., Centner, C.M., Olaru, I.D., Donà, D., Burzo, S., Huttner, B.D., Chaillon, A., Gebreselassie, N., Wi, T. and Hasso-Agopsowicz, M., 2024. WHO global research priorities fo...
Geospatial correlations and variations in child mortality and stunting in South Africa: Evaluating distal vs structural determinants.

Wand, H., Moodley, J., Reddy, T. and Naidoo, S., 2024. Geospatial Correlations and Variations in Child Mortality and Stunting in South Africa: Evaluating Distal vs Structural Determinants. Spatial an...
Navigating complex care pathways-healthcare workers' perspectives on health system barriers for children with tuberculous meningitis in Cape Town, South Africa.

Baloyi, D.P., Myburgh, H., Bester, D., Anthony, M.G., Switala, J., Schaaf, H.S., Naidoo, L., Solomons, R., Nuttall, J., Murray, J. and Rohlwink, U., 2024. Navigating complex care pathways–healthcare...
Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis.

Hamada, Y., Quartagno, M., Malik, F., Ntshamane, K., Tisler, A., Gaikwad, S., Acuna‐Villaorduna, C., Bhavani, P.K., Alisjahbana, B., Ronacher, K. and Apriani, L., 2024. Prevalence of non‐communica...
Strengthening the Application of the DAIDS GCLP Guidelines: The Implementation of an Integrated Laboratory Oversight Framework.

Nguyen, L., Leach, A., Piwowar-Manning, E., Marzinke, M., Levesque, A., Gregorio, C., Skinner, K., Towindo, T., Hanes, H., Sarpong, K. and Kasongo, C., 2024. Strengthening the Application of the DAIDS...
Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.

Stejskal, L., Thistlethwaite, A., Ramirez-Bencomo, F., Rashmi, S., Harrison, O., Feavers, I.M., Maiden, M.C., Jerse, A., Barnes, G., Chirro, O. and Chemweno, J., 2024. Profiling IgG and IgA antibody r...
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.

Bekker, L.G., Das, M., Abdool Karim, Q., Ahmed, K., Batting, J., Brumskine, W., Gill, K., Harkoo, I., Jaggernath, M., Kigozi, G. and Kiwanuka, N., 2024. Twice-yearly lenacapavir or daily F/TAF for HIV...
Prevalence and associated risk factors of chlamydia and gonorrhoea infections among men who have sex with men in Durban, South Africa.

Mofolorunsho, K.C., Mabaso, N., Nundlall, N., Nightingale, A., Nyirenda, M. and Abbai, N., 2024. Prevalence and associated risk factors of chlamydia and gonorrhoea infections among men who have sex wi...
Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702. Vaccine.

Chihana, R., Kee, J.J., Moodie, Z., Huang, Y., Janes, H., Dadabhai, S., Roxby, A.C., Allen, M., Kassim, S., Naicker, V. and Innes, C., 2024. Factors associated with reactogenicity to an investigationa...
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.

Rodriguez, C.A., Natukunda, E., Strehlau, R., Venter, E.L., Rungmaitree, S., Cunningham, C.K., Lalloo, U., Kosalaraksa, P., HellstrÖm, E., Liberty, A. and McGrath, E.J., 2024. Pharmacokinetics and sa...
Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines).

Hansen, M.A., Lekodeba, N.A., Chevalier, J.M., Ockhuisen, T., del Rey-Puech, P., Marban-Castro, E., Martínez-Pérez, G.Z., Shilton, S., Hassan, M.R.A., Getia, V. and Weinert-Mizuschima, C., 2024. Cos...

Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.

Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatment.

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.

WhatsApp Versus SMS for 2-Way, Text-Based Follow-Up After Voluntary Medical Male Circumcision in South Africa: Exploration of Messaging Platform Choice.

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-imp

Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.

Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis:

WHO global research priorities for antimicrobial resistance in human health.

Geospatial correlations and variations in child mortality and stunting in South Africa: Evaluating distal vs structural determinants.

Navigating complex care pathways-healthcare workers' perspectives on health system barriers for children with tuberculous meningitis in Cape Town, South Africa.

Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis.

Strengthening the Application of the DAIDS GCLP Guidelines: The Implementation of an Integrated Laboratory Oversight Framework.

Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.

Prevalence and associated risk factors of chlamydia and gonorrhoea infections among men who have sex with men in Durban, South Africa.

Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702. Vaccine.

Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.

Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines).

Popular Tags

Most Read

Recent Posts